I have created this chart to visually represent the universal role Bisantrene plays in cardioprotection against common cardiotoxic chemotherapies. A 1 uM dose of Bisantrene significantly improves HCM viability (p < 0.001). The real value for this opportunity is that while providing cardioprotection, Bisantrene improves cancer cell killing in combination with these chemotherapies. There are already 2 clinical trials where Bisantrene is used in combination with moderately cardiotoxic chemotherapies not listed in the figure below that achieved combined ORR of 46% and 40% with no clinically relevant signs of cardiotoxicity.
A drug with a universal cardioprotection mechanism combined with a universal cytotoxicity mechanism has not existed until now.
- Forums
- ASX - By Stock
- Cardioprotection thread
I have created this chart to visually represent the universal...
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.79 |
Change
-0.075(4.02%) |
Mkt cap ! $304.8M |
Open | High | Low | Value | Volume |
$1.86 | $1.86 | $1.76 | $348.2K | 192.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5612 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 3567 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5612 | 1.770 |
2 | 3718 | 1.760 |
1 | 1709 | 1.755 |
1 | 6191 | 1.750 |
1 | 332 | 1.740 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 3567 | 1 |
1.830 | 1000 | 1 |
1.840 | 4543 | 2 |
1.890 | 7332 | 2 |
1.905 | 2032 | 1 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.78 |
  |
Change
-0.075 ( 5.38 %) |
|||
Open | High | Low | Volume | ||
$1.81 | $1.86 | $1.76 | 27553 | ||
Last updated 15.55pm 14/06/2024 ? |
Featured News
RAC (ASX) Chart |